Trial
NCT01113502
Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Acute Myelogenous Leukemia (AML)
Intervention
Eltrombopag
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-05